Gene Page:SYTL2
概括?
基因 | 54843 |
Symbol | SYTL2 |
Synonyms | CHR11SYT|EXO4|PPP1R151|SGA72M|SLP2|SLP2A |
Description | synaptotagmin like 2 |
Reference | MIM:612880|HGNC:HGNC:15585|Ensembl:ENSG00000137501|HPRD:10260|Vega:OTTHUMG00000166977 |
Gene type | protein-coding |
Map location | 11q14 |
Pascal p-value | 0.084 |
Sherlock p-value | 0.936 |
度p-value | DEG:Zhao_2015:p=4.51e-04:q=0.0926 |
Fetal beta | -2.918 |
eGene | Myers' cis & trans |
Support | EXOCYTOSIS |
数据源中的基因
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS | |
DEG:Zhao_2015 | RNA Sequencing analysis | 转录组测序和全基因组的关联分析揭示了精神分裂症和躁郁症中的溶酶体功能和肌动蛋白细胞骨架重塑。 | |
GO_Annotation | Mapping neuro-related keywords to Gene Ontology annotations | 与神经相关关键字的命中:2 |
Section I. Genetics and epigenetics annotation
eQTL annotation
SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
rs639688 | chr11 | 85470892 | SYTL2 | 54843 | 0.03 | cis | ||
rs17817179 | chr11 | 85525568 | SYTL2 | 54843 | 0.12 | cis | ||
rs12335203 | chr8 | 73953618 | SYTL2 | 54843 | 0.09 | trans | ||
rs7186114 | chr16 | 66839221 | SYTL2 | 54843 | 0.2 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)
![Not available](http://www.tjghsg.com/bioinfo/SZGR/GeneImg/SYTL2_DE_GTEx.png)
Gene expression during devlopment (BrainCloud)
Footnote:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
Top 10 positively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
RMI1 | 0.89 | 0.86 |
RECQL | 0.88 | 0.84 |
SLMO2 | 0.88 | 0.86 |
COPB1 | 0.87 | 0.86 |
ASF1A | 0.87 | 0.81 |
CPSF3 | 0.87 | 0.84 |
ZNF561 | 0.86 | 0.87 |
KIAA1712 | 0.86 | 0.84 |
LIN9 | 0.86 | 0.83 |
AP002373.1 | 0.86 | 0.80 |
Top 10 negatively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
MT-CO2 | -0.61 | -0.72 |
AF347015.8 | -0.60 | -0.72 |
AF347015.31 | -0.60 | -0.71 |
MT-CYB | -0.60 | -0.71 |
AF347015.27 | -0.60 | -0.70 |
AF347015.15 | -0.58 | -0.72 |
AF347015.33 | -0.58 | -0.69 |
AF347015.2 | -0.57 | -0.69 |
IFI27 | -0.56 | -0.69 |
AF347015.21 | -0.55 | -0.69 |
Section III. Gene Ontology annotation
Molecular function | 去的术语 | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
GO:0042043 | neurexin binding | ISS | Synap(术语级别:4) | - |
GO:0005215 | 运输er activity | IEA | - | |
GO:0017137 | Rab GTPase binding | IEA | - | |
GO:0031177 | phosphopantetheine binding | IEA | - | |
生物过程 | 去的术语 | Evidence | Neuro keywords | PubMed ID |
GO:0006810 | 运输 | IEA | - | |
GO:0006886 | intracellular protein transport | IEA | - | |
GO:0016192 | 囊泡介导的运输 | ISS | - | |
Cellular component | 去的术语 | Evidence | Neuro keywords | PubMed ID |
GO:0008021 | synaptic vesicle | IEA | Synap, Neurotransmitter (GO term level: 12) | - |
GO:0012505 | endomembrane system | IEA | - | |
GO:0005624 | membrane fraction | ISS | - | |
去:0016020 | membrane | IEA | - | |
GO:0019897 | extrinsic to plasma membrane | ISS | - | |
GO:0042470 | melanosome | ISS | - |
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
CHEMNITZ RESPONSE TO PROSTAGLANDIN E2 DN | 391 | 222 | 该途径中的所有SZGR 2.0基因 |
DEURIG T CELL PROLYMPHOCYTIC LEUKEMIA DN | 320 | 184 | 该途径中的所有SZGR 2.0基因 |
BASAKI YBX1 TARGETS DN | 384 | 230 | 该途径中的所有SZGR 2.0基因 |
WANG LMO4 TARGETS DN | 352 | 225 | 该途径中的所有SZGR 2.0基因 |
SENESE HDAC1 AND HDAC2 TARGETS DN | 232 | 139 | 该途径中的所有SZGR 2.0基因 |
WAMUNYOKOLI OVARIAN CANCER LMP UP | 265 | 158 | 该途径中的所有SZGR 2.0基因 |
WAMUNYOKOLI OVARIAN CANCER GRADES 1 2 UP | 137 | 84 | 该途径中的所有SZGR 2.0基因 |
DODD NASOPHARYNGEAL CARCINOMA UP | 1821 | 933 | 该途径中的所有SZGR 2.0基因 |
RODRIGUES THYROID CARCINOMA ANAPLASTIC UP | 722 | 443 | 该途径中的所有SZGR 2.0基因 |
RODRIGUES THYROID CARCINOMA DN | 77 | 52 | 该途径中的所有SZGR 2.0基因 |
GOZGIT ESR1 TARGETS DN | 781 | 465 | 该途径中的所有SZGR 2.0基因 |
LINDGREN BLADDER CANCER CLUSTER 3 DN | 229 | 142 | 该途径中的所有SZGR 2.0基因 |
GAUSSMANN MLL AF4 FUSION TARGETS G UP | 238 | 135 | 该途径中的所有SZGR 2.0基因 |
PATIL LIVER CANCER | 747 | 453 | 该途径中的所有SZGR 2.0基因 |
YORDY RECIPROCAL REGULATION BY ETS1 AND SP100 DN | 87 | 48 | 该途径中的所有SZGR 2.0基因 |
NUYTTEN EZH2 TARGETS DN | 1024 | 594 | 该途径中的所有SZGR 2.0基因 |
RICKMAN TUMOR DIFFERENTIATED MODERATELY VS POORLY UP | 121 | 71 | 该途径中的所有SZGR 2.0基因 |
LIN SILENCED BY TUMOR MICROENVIRONMENT | 108 | 73 | 该途径中的所有SZGR 2.0基因 |
NIKOLSKY BREAST CANCER 11Q12 Q14 AMPLICON | 158 | 93 | 该途径中的所有SZGR 2.0基因 |
NIKOLSKY MUTATED AND AMPLIFIED IN BREAST CANCER | 94 | 60 | 该途径中的所有SZGR 2.0基因 |
MATSUDA NATURAL KILLER DIFFERENTIATION | 475 | 313 | 该途径中的所有SZGR 2.0基因 |
Traynor Rett综合征 | 45 | 33 | 该途径中的所有SZGR 2.0基因 |
RODWELL AGING KIDNEY NO BLOOD UP | 222 | 139 | 该途径中的所有SZGR 2.0基因 |
RODWELL AGING KIDNEY UP | 487 | 303 | 该途径中的所有SZGR 2.0基因 |
Creighton内分泌疗法抗性1 | 528 | 324 | 该途径中的所有SZGR 2.0基因 |
GAVIN FOXP3 TARGETS CLUSTER P3 | 160 | 103 | 该途径中的所有SZGR 2.0基因 |
GAVIN PDE3B TARGETS | 22 | 15 | 该途径中的所有SZGR 2.0基因 |
MARSON BOUND BY FOXP3 STIMULATED | 1022 | 619 | 该途径中的所有SZGR 2.0基因 |
MARSON BOUND BY FOXP3 UNSTIMULATED | 1229 | 713 | 该途径中的所有SZGR 2.0基因 |
OSADA ASCL1 TARGETS UP | 46 | 30 | 该途径中的所有SZGR 2.0基因 |
ACEVEDO混入甲醇D IN LIVER CANCER DN | 940 | 425 | 该途径中的所有SZGR 2.0基因 |
SMID BREAST CANCER BASAL DN | 701 | 446 | 该途径中的所有SZGR 2.0基因 |
IZADPANAH STEM CELL ADIPOSE VS BONE DN | 108 | 68 | 该途径中的所有SZGR 2.0基因 |
LEE RECENT THYMIC EMIGRANT | 227 | 128 | 该途径中的所有SZGR 2.0基因 |
GYORFFY MITOXANTRONE RESISTANCE | 57 | 35 | 该途径中的所有SZGR 2.0基因 |
LI INDUCED T TO NATURAL KILLER UP | 307 | 182 | 该途径中的所有SZGR 2.0基因 |
CHICAS RB1 TARGETS CONFLUENT | 567 | 365 | 该途径中的所有SZGR 2.0基因 |
DUTERTRE ESTRADIOL RESPONSE 24HR DN | 505 | 328 | 该途径中的所有SZGR 2.0基因 |
BHAT ESR1 TARGETS NOT VIA AKT1 DN | 88 | 61 | 该途径中的所有SZGR 2.0基因 |
BHAT ESR1 TARGETS VIA AKT1 DN | 82 | 51 | 该途径中的所有SZGR 2.0基因 |
FEVR CTNNB1 TARGETS UP | 682 | 433 | 该途径中的所有SZGR 2.0基因 |
KATSANOU ELAVL1 TARGETS UP | 169 | 105 | 该途径中的所有SZGR 2.0基因 |
KRIEG HYPOXIA NOT VIA KDM3A | 770 | 480 | 该途径中的所有SZGR 2.0基因 |
ZWANG TRANSIENTLY UP BY 1ST EGF PULSE ONLY | 1839 | 928 | 该途径中的所有SZGR 2.0基因 |
Section VI. microRNA annotation
miRNA family | Target position | miRNA ID | miRNA seq | ||
---|---|---|---|---|---|
UTR start | UTR end | Match method | |||
miR-384 | 234 | 241 | 1A,m8 | hsa-miR-384 | AUUCCUAGAAAUUGUUCAUA |
- SZ: miRNAs which differentially expressed in brain cortex of schizophrenia patients comparing with control samples using microarray. Clickhereto see the list of SZ related miRNAs.
- Brain: miRNAs which are expressed in brain based on miRNA microarray expression studies. Clickhereto see the list of brain related miRNAs.